Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Remus Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 1161.70 P/BV 11.56 Book Value ( ₹ ) 170.55
52 Week High/Low ( ₹ ) 2835/1785 FV/ML 10/50 P/E(X) 39.96
Book Closure 20/11/2024 EPS ( ₹ ) 49.34 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 25Mar 24
Months1212
Source Of Info (AR = Annual Report, PR = Press Release)PRAR
FaceValue10.0010.00
   
   
INCOME  
Revenue From Operations [Net]620.36212.50
Total Operating Revenues620.36212.50
   
Other Income4.985.40
Total Revenue625.34217.90
   
EXPENSES  
Purchase Of Stock-In Trade541.31164.99
Changes In Inventories Of FG,WIP And Stock-In Trade-8.44-0.67
Employee Benefit Expenses13.117.42
Finance Costs1.460.48
Depreciation And Amortisation Expenses1.870.90
Other Expenses28.6912.94
Total Expenses578.00186.07
   
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax47.3431.83
   
Profit/Loss Before Tax47.3431.83
   
Tax Expenses-Continued Operations  
Current Tax8.926.60
Deferred Tax0.00-0.71
Tax For Earlier Years0.00-0.03
Total Tax Expenses8.925.85
Profit/Loss After Tax And Before ExtraOrdinary Items38.4225.98
   
Profit/Loss From Continuing Operations38.4225.98
   
Profit/Loss For The Period38.4225.98
   
Minority Interest-9.350.00
Consolidated Profit/Loss After MI And Associates29.0725.98
   
OTHER INFORMATION  
   
EARNINGS PER SHARE  
Basic EPS (Rs.)65.21152.01
Diluted EPS (Rs.)65.21152.01
   
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend0.000.59
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]620.36
Total Operating Revenues620.36
Other Income4.98
Total Revenue625.34
EXPENSES 
Purchase Of Stock-In Trade541.31
Changes In Inventories Of FG,WIP And Stock-In Trade-8.44
Employee Benefit Expenses13.11
Finance Costs1.46
Depreciation And Amortisation Expenses1.87
Other Expenses28.69
Total Expenses578.00
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax47.34
Profit/Loss Before Tax47.34
Tax Expenses-Continued Operations 
Current Tax8.92
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses8.92
Profit/Loss After Tax And Before ExtraOrdinary Items38.42
Profit/Loss From Continuing Operations38.42
Profit/Loss For The Period38.42
Minority Interest-9.35
Consolidated Profit/Loss After MI And Associates29.07
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)65.21
Diluted EPS (Rs.)65.21
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00